arrow
P

Parunya Chaiyawat

Chiang Mai University
H指数:19
被引数:945

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Distinct Bone Marrow Metabolic Profiles at Relapse Compared with Initial Diagnosis in Pediatric Acute Lymphoblastic Leukemia—An LC-MS Metabolomics Study

与初诊相比,儿童急性淋巴细胞白血病复发时骨髓代谢谱的差异——一项LC-MS代谢组学研究

Cancers
IF4.4
2026-09-210
OA
Performance and pilot clinical validation of MALDITEC-CTC: a circulating tumor cell detection platform using whole-cell MALDI-TOF MS fingerprinting in osteosarcoma

MALDITEC-CTC平台的性能及初步临床验证:一种在骨肉瘤中利用全细胞MALDI-TOF质谱指纹图谱检测循环肿瘤细胞的平台

2026-06-160
OAAI
Efficacy and safety of mycophenolate mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): a multicenter, phase II clinical trial

吗替麦考酚酯在局部晚期或转移性骨肉瘤(ESMMO)患者中的有效性和安全性:一项多中心、II期临床试验

2025-09-120
PRE
A Novel Homozygous Missense Variant of PIGT Related to Multiple Congenital Anomalies-Hypotonia Seizures Syndrome 3 with Elevated of Serum ALP Level in a Thai Newborn Patient

一种与PIGT相关的、导致泰国新生儿患者出现多种先天性异常-肌张力减退-癫痫综合征3型且伴有血清ALP水平升高的新型纯合错义变异。

2025-03-200
OA
Establishment, characterization, and genetic profiling of patient-derived osteosarcoma cells from a patient with retinoblastoma (vol 14, 11056, 2024)
2024-09-100
OAAI
Establishment, characterization, and genetic profiling of patient-derived osteosarcoma cells from a patient with retinoblastoma
2024-05-142
OAAI
Expression profiling of DNA methyl transferase I (DNMT1) and efficacy of a DNA-hypomethylating agent (decitabine) in combination with chemotherapy in osteosarcoma

DNA甲基转移酶I (DNMT1) 的表达谱以及DNA低甲基化试剂 (地西他滨) 与化疗联合治疗骨肉瘤的疗效

2020-12-017
OAAI
Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): rationale and design of the ESMMO trial

II期,多中心,开放标签,单臂临床试验,评估霉酚酸酯在高级别局部晚期或转移性骨肉瘤 (ESMMO) 患者中的疗效和安全性: ESMMO试验的原理和设计

2020-03-3014
OAAI